We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-16.9%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$15.5B
AUM Growth
-$3.84B
Cap. Flow
-$233M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.9%
Holding
147
New
6
Increased
46
Reduced
82
Closed
12

Top Buys

Rank Stock Value
1
BBWI icon
Bath & Body Works
BBWI
+$131M
2
FRPT icon
Freshpet
FRPT
+$102M
3
FDS icon
Factset
FDS
+$102M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$90.2M
5
FRSH icon
Freshworks
FRSH
+$87.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.59%
2 Industrials 18.31%
3 Technology 18.13%
4 Financials 15.23%
5 Consumer Staples 12.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRL icon
51
Hormel Foods
HRL
$14.2B
$125M 0.81%
2,631,405
-771,960
-23% -$38.5M
MASI
52
DELISTED
Masimo
MASI
$124M 0.8%
951,742
-23,805
-2% -$3.18M
BL icon
53
BlackLine
BL
$1.93B
$124M 0.8%
1,856,040
+469,660
+34% +$32.2M
ULTA icon
54
Ulta Beauty
ULTA
$22B
$122M 0.79%
317,129
-32,366
-9% -$12.9M
NEWR
55
DELISTED
New Relic, Inc.
NEWR
$122M 0.79%
2,435,865
-91,765
-4% -$5.09M
SIGI icon
56
Selective Insurance
SIGI
$5.72B
$121M 0.78%
1,396,160
-47,440
-3% -$3.86M
SIVB
57
DELISTED
SVB Financial Group
SIVB
$121M 0.78%
305,188
-4,567
-1% -$2.15M
TWNK
58
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$115M 0.74%
5,421,675
-830,970
-13% -$18M
BIO icon
59
Bio-Rad Laboratories Class A
BIO
$8.75B
$113M 0.73%
228,510
-15,995
-7% -$8.33M
DXCM icon
60
DexCom
DXCM
$29.3B
$113M 0.73%
1,510,578
+934,258
+162% +$85.3M
UMBF icon
61
UMB Financial
UMBF
$11.3B
$111M 0.72%
1,288,035
-47,510
-4% -$4.31M
MGPI icon
62
MGP Ingredients
MGPI
$424M
$110M 0.71%
1,094,205
-307,190
-22% -$28.9M
WLY icon
63
John Wiley & Sons Class A
WLY
$2.86B
$107M 0.69%
2,235,060
-65,375
-3% -$3.34M
SMPL icon
64
Simply Good Foods
SMPL
$919M
$105M 0.68%
2,784,234
-1,778,565
-39% -$70.5M
FDS icon
65
Factset
FDS
$10.2B
$99.8M 0.65%
+259,565
New +$102M
INDB icon
66
Independent Bank
INDB
$4.09B
$98.5M 0.64%
1,239,755
-222,655
-15% -$17.7M
TENB icon
67
Tenable Holdings
TENB
$3.56B
$97.7M 0.63%
2,150,735
-409,610
-16% -$21.1M
GMED icon
68
Globus Medical
GMED
$11.1B
$97.3M 0.63%
1,732,865
+55,550
+3% +$3.65M
QTWO icon
69
Q2 Holdings
QTWO
$3.85B
$96.3M 0.62%
2,497,880
+130,655
+6% +$6.35M
ZEN
70
DELISTED
ZENDESK INC
ZEN
$95.8M 0.62%
1,294,000
-596,860
-32% -$58.8M
WK icon
71
Workiva
WK
$3.46B
$93.1M 0.6%
1,410,170
+310,375
+28% +$25.8M
ELF icon
72
e.l.f. Beauty
ELF
$4.95B
$91.9M 0.59%
2,995,545
+59,995
+2% +$1.51M
TRS icon
73
TriMas Corp
TRS
$1.43B
$88.4M 0.57%
3,191,490
-156,420
-5% -$4.52M
IOSP icon
74
Innospec
IOSP
$2.1B
$87.5M 0.57%
913,480
-36,240
-4% -$3.52M
ASAN icon
75
Asana
ASAN
$1.95B
$85.9M 0.56%
4,885,464
-822,760
-14% -$20.7M

Similar funds

Champlain Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Champlain Investment Partners held 147 positions worth $15.5B, down 20% from $19.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners's Q2 2022 filing shows 6 new, 46 increased, 82 reduced and 12 closed positions. Its largest new stake was Bath & Body Works: 3,015,567 shares worth $81.2M. The largest sale was SailPoint Technologies Holdings, Inc. Common Stock, an estimated $149M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Technology.

  • Champlain Investment Partners's largest Q2 2022 buy was Bath & Body Works: 3,015,567 shares worth $81.2M.
  • Champlain Investment Partners added most to Freshpet in Q2 2022, an estimated $102M increase.
  • Champlain Investment Partners's biggest Q2 2022 reduction was Clarivate, cutting an estimated $125M.
  • Champlain Investment Partners fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q2 2022, selling an estimated $149M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $15.5B portfolio in Q2 2022.
  • Champlain Investment Partners opened 6 new positions and closed 12 in Q2 2022.
  • Champlain Investment Partners's portfolio value fell 20% quarter-over-quarter to $15.5B.

Based on Champlain Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.